Unclassified Renal Cell Carcinoma
5 clinical trials · Condition
◉ Watch Unclassified Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC (NCT04413123) | Bradley A. McGregor, MD | 2020-11-05 |
| Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study (NCT04071223) | National Cancer Institute (NCI) | 2020-07-29 |
| A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma (NCT03635892) | Memorial Sloan Kettering Cancer Center | 2018-08-13 |
| Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma (NCT03541902) | M.D. Anderson Cancer Center | 2018-05-15 |
Track Unclassified Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.